Cline Darren S 4
4 · IMPEL PHARMACEUTICALS INC · Filed Apr 14, 2023
Insider Transaction Report
Form 4
Cline Darren S
Director
Transactions
- Award
Stock Option (right to buy)
2023-04-12+20,013→ 20,013 totalExercise: $1.42Exp: 2033-04-11→ Common Stock (20,013 underlying)
Footnotes (1)
- [F1]The option vests as to 1/3rd of the total shares on April 12, 2024 and then 1/36th of the total shares vests on each monthly anniversary thereafter, with 100% of the total shares vested and exercisable on April 12, 2026, subject to the reporting person's provision of service to the issuer on each vesting date.